Human genetic diversity alters off-target outcomes of therapeutic gene editing.

Human genetic diversity alters off-target outcomes of therapeutic gene editing.
复制标题

DOI:
10.1038/s41588-022-01257-y
复制
发表时间:
2023-01
期刊:
影响因子:
30.8
通讯作者:
Pinello, Luca
Pinello, Luca
中科院分区:
生物学1区
文献类型:
--
作者:
Cancellieri, Samuele;Zeng, Jing;Lin, Linda Yingqi;Tognon, Manuel;Nguyen, My Anh;Lin, Jiecong;Bombieri, Nicola;Maitland, Stacy A.;Ciuculescu, Marioara-Felicia;Katta, Varun;Tsai, Shengdar Q.;Armant, Myriam;Wolfe, Scot A.;Giugno, Rosalba;Bauer, Daniel E.;Pinello, Luca

文献摘要

参考文献

被引文献

相似文献

CRISPR基因编辑有望修改体细胞中的DNA序列以治疗疾病。然而,预测脱靶潜力的标准计算和生物化学方法集中于参考基因组。我们开发了一种名为CRISPRme的有效工具,该工具考虑SNP和indel遗传变异来提名和优先考虑脱靶位点。我们用BCL11A增强子靶向向导RNA测试了该软件,该软件在镰状细胞病和β地中海贫血的临床试验中显示出希望,并发现最佳候选脱靶是由非洲血统人群中常见的等位基因(MAF 4.5%)产生的,该等位基因引入了原型间隔区邻近基序(PAM)序列。我们验证了SpCas9在CD34+ HSPC中产生严格的等位基因特异性插入缺失和臂间倒位,尽管高保真Cas9减轻了这种脱靶。本报告说明了遗传变异应如何被视为基因编辑结果的修饰符。我们预计,变体感知脱靶评估将成为治疗性基因组编辑评估的组成部分,并为全面的脱靶提名提供强有力的方法。
CRISPR gene editing holds great promise to modify DNA sequences in somatic cells to treat disease. However, standard computational and biochemical methods to predict off-target potential focus on reference genomes. We developed an efficient tool called CRISPRme that considers SNP and indel genetic variants to nominate and prioritize off-target sites. We tested the software with a BCL11A enhancer targeting guide RNA showing promise in clinical trials for sickle cell disease and β-thalassemia and found that the top candidate off-target is produced by an allele common in African-ancestry populations (MAF 4.5%) that introduces a protospacer adjacent motif (PAM) sequence. We validated that SpCas9 generates strictly allele-specific indels and pericentric inversions in CD34+ HSPCs, although high-fidelity Cas9 mitigates this off-target. This report illustrates how genetic variants should be considered as modifiers of gene editing outcomes. We expect that variant-aware off-target assessment will become integral to therapeutic genome editing evaluation and provide a powerful approach for comprehensive off-target nomination.
DOI: 10.1056/nejmoa1710504
发表时间: 2018-02-15
影响因子: 158.5
作者:
Mercuri, E.;Darras, B. T.;Kim, Hyuna
通讯作者: Kim, Hyuna
DOI: 10.1038/nbt.3437
发表时间: 2016-02
影响因子: 46.9
作者:
Doench JG;Fusi N;Sullender M;Hegde M;Vaimberg EW;Donovan KF;Smith I;Tothova Z;Wilen C;Orchard R;Virgin HW;Listgarten J;Root DE
通讯作者: Root DE
DOI: 10.1093/nar/gky955
发表时间: 2019-01-08
影响因子: 14.9
作者:
Frankish A;Diekhans M;Ferreira AM;Johnson R;Jungreis I;Loveland J;Mudge JM;Sisu C;Wright J;Armstrong J;Barnes I;Berry A;Bignell A;Carbonell Sala S;Chrast J;Cunningham F;Di Domenico T;Donaldson S;Fiddes IT;García Girón C;Gonzalez JM;Grego T;Hardy M;Hourlier T;Hunt T;Izuogu OG;Lagarde J;Martin FJ;Martínez L;Mohanan S;Muir P;Navarro FCP;Parker A;Pei B;Pozo F;Ruffier M;Schmitt BM;Stapleton E;Suner MM;Sycheva I;Uszczynska-Ratajczak B;Xu J;Yates A;Zerbino D;Zhang Y;Aken B;Choudhary JS;Gerstein M;Guigó R;Hubbard TJP;Kellis M;Paten B;Reymond A;Tress ML;Flicek P
通讯作者: Flicek P
DOI: 10.1038/s41591-018-0327-9
发表时间: 2019-02-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Maeder, Morgan L.;Stefanidakis, Michael;Jiang, Haiyan
通讯作者: Jiang, Haiyan
DOI: 10.1038/s41586-020-2308-7
发表时间: 2020-05-01
期刊: Nature
影响因子: 64.8
作者:
Karczewski, Konrad J;Francioli, Laurent C;MacArthur, Daniel G
通讯作者: MacArthur, Daniel G